₹ 156.65 Cr
2.34%
NIFTY Healthcare TRI
INF00XX01BL5
5000.0
1000.0
500
Dhimant Shah, Rohan Korde, Rajesh Bhatia
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 42.92 | - | - |
NIFTY Healthcare TRI | 50.07 | 13.77 | 22.74 |
Equity
Debt
Others
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 15.87 |
Dr. Reddy's Laboratories Ltd. | 7.24 |
Lupin Ltd. | 6.19 |
Max Healthcare Institute Ltd. | 5.69 |
Apollo Hospitals Enterprise Ltd. | 4.82 |
Divi's Laboratories Ltd. | 4.6 |
Suven Pharmaceuticals Ltd. | 4.43 |
Zydus Lifesciences Ltd. | 3.93 |
Laurus Labs Ltd. | 2.82 |
Syngene International Ltd. | 2.58 |
Sector | Holdings (%) |
---|---|
Healthcare | 96.77 |
Chemicals | 2.75 |
Others | 0.48 |
Scheme Name | 5Y (%) |
---|---|
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 27.6 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 25.17 |
UTI Healthcare Reg Gr | 24.81 |
Nippon India Pharma Fund Gr Gr | 26.37 |
Mirae Asset Healthcare Reg Gr | 27.12 |
LIC MF Healthcare Fund Reg Gr | 20.85 |
SBI HEALTHCARE Opportunities Reg Gr | 26.98 |
DSP Healthcare Reg Gr | 27.95 |